Skip to content

Insider · CIK 0001492766

Hans Lennart Rudolf Wigzell

director

Files at SRPT (Sarepta Therapeutics, Inc.). First filing Dec 16, 2024, latest Dec 16, 2024.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 1
$0 bought, $1.3M sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

SRPT: Sarepta Therapeutics, Inc.

SRPTOct 9, 2026 · close 17.85

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
43Moderate
SRPTsell 2
Sarepta Therapeutics, Inc.
$1.3M
10,500 shares
-31%-

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Dec 12, 2024SRPT
Sarepta Therapeutics, Inc.
MOption exercise
Common Stock
+10,500$13.71$144k33,340Dec 16, 2024
Dec 12, 2024SRPT
Sarepta Therapeutics, Inc.
SOpen-market sale
Common Stock
-10,500$124.84$1.3M22,840Dec 16, 2024
Dec 12, 2024SRPT
Sarepta Therapeutics, Inc.
MOption exercise
Stock Options (right to buy)derivative
-10,500$0.00$00Dec 16, 2024

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Hans Lennart Rudolf Wigzell: insider trades and track record | InsiderTell